Perrigo Vice Chair Mori Arkin To Retire After 30 Years ...( ALLEGAN Mich. Sept. 13 /- Perrigo...),Health

ALLEGAN, Mich., Sept. 13 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Mori Arkin, Vice Chairman and General Manager, Perrigo Global Generics and API, has advised the Company that he will retire at the expiration of his current employment agreement on March 17, 2008. Mr. Arkin will remain in his current role until that time, managing the business and ensuring an orderly transition. Arkin will remain a member of the Company's Board of Directors and continue to assist the Company as needed.

Arkin joined Perrigo as Vice Chairman and has served as a director since March 2005. Before joining Perrigo, Arkin served as Chairman of the Board of Directors and was the principal shareholder of Agis Industries (1983) Ltd., now known as Perrigo Israel Pharmaceuticals Ltd., from its establishment in 1983 (and prior to that of its affiliated companies) until its acquisition by Perrigo in March 2005.

"Mori has done an outstanding job of moving the Company forward during his tenure as Vice Chairman," said Joseph C. Papa, Perrigo's President and CEO. "The strategic direction put in place under Mori's leadership, with its emphasis on continued growth of the generic Rx business in the US and expansion of the API business around the world will remain in place, and the Company will continue to move forward under the current business plan."

After his departure, the Global Generic and API leadership team will report directly to Perrigo's President and CEO. Rafi Lebel, EVP and General Manager of Perrigo Israel, who has been with the Company for more than 19 years, will continue to lead the API, Consumer Products and Pharmaceutical Diagnostics businesses. Jatin Shah, SVP and Chief Scientif
'/>"/>